Validated stability-indicating spectrofluorimetric methods for the determination of ebastine in pharmaceutical preparations

Table 7 Determination of ebastine in its dosage forms using method I

Parameter	Amount taken (μg/ml)	Amount found (μg/ml)	% Recovery	Comparison method³,% Recovery
Bastab ^® tablets containing 20 mg ebastine/tablet	0.1	0.099	99.71	99.23
	0.2	0.199	99.52	99.61
	0.3	0.301	100.33	100.61
	0.5	0.503	100.62
	0.6	0.602	100.33
	0.8	0.798	99.75
	1.0	1.01	100.64
Xˉ ± SD			100.13 ± 0.46	99.82 ± 0.71
Student's t test			0.27 (1.94)*
F test			2.38 (5.14)*
Evastine ^® syrup containing 5 mg ebastine/5ml	0.1	0.101	100.96	100.12
	0.2	0.201	100.55	99.61
	0.3	0.301	100.33	99.51
	0.5	0.499	99.81
	0.6	0.598	99.67
	0.8	0.801	100.13
	1.0	1.01	100.93
Xˉ ± SD			100.34 ± 0.51	99.75 ± 0.33
Student's t test			0.34 (1.94)*
F test			2.39 (5.14)*

ISSN: 2661-801X